Matches in Wikidata for { <http://www.wikidata.org/entity/Q50442905> ?p ?o ?g. }
- Q50442905 description "2015 nî lūn-bûn" @default.
- Q50442905 description "2015 թվականի հունիսի 10-ին հրատարակված գիտական հոդված" @default.
- Q50442905 description "2015年の論文" @default.
- Q50442905 description "2015年学术文章" @default.
- Q50442905 description "2015年学术文章" @default.
- Q50442905 description "2015年学术文章" @default.
- Q50442905 description "2015年学术文章" @default.
- Q50442905 description "2015年学术文章" @default.
- Q50442905 description "2015年学术文章" @default.
- Q50442905 description "2015年學術文章" @default.
- Q50442905 description "2015年學術文章" @default.
- Q50442905 description "2015年學術文章" @default.
- Q50442905 description "2015年學術文章" @default.
- Q50442905 description "2015年學術文章" @default.
- Q50442905 description "2015년 논문" @default.
- Q50442905 description "article científic" @default.
- Q50442905 description "article scientific" @default.
- Q50442905 description "article scientifique" @default.
- Q50442905 description "articol științific" @default.
- Q50442905 description "articolo scientifico" @default.
- Q50442905 description "artigo científico" @default.
- Q50442905 description "artigo científico" @default.
- Q50442905 description "artigo científico" @default.
- Q50442905 description "artikel ilmiah" @default.
- Q50442905 description "artikull shkencor" @default.
- Q50442905 description "artikulong pang-agham" @default.
- Q50442905 description "artykuł naukowy" @default.
- Q50442905 description "artículo científico publicado en 2015" @default.
- Q50442905 description "artículu científicu" @default.
- Q50442905 description "bilimsel makale" @default.
- Q50442905 description "bài báo khoa học" @default.
- Q50442905 description "naučni članak" @default.
- Q50442905 description "scienca artikolo" @default.
- Q50442905 description "scientific article published on 10 June 2015" @default.
- Q50442905 description "scientific article published on 10 June 2015" @default.
- Q50442905 description "scientific article published on 10 June 2015" @default.
- Q50442905 description "teaduslik artikkel" @default.
- Q50442905 description "tieteellinen artikkeli" @default.
- Q50442905 description "tudományos cikk" @default.
- Q50442905 description "vedecký článok" @default.
- Q50442905 description "vetenskaplig artikel" @default.
- Q50442905 description "videnskabelig artikel" @default.
- Q50442905 description "vitenskapelig artikkel" @default.
- Q50442905 description "vitskapeleg artikkel" @default.
- Q50442905 description "vědecký článek" @default.
- Q50442905 description "wetenschappelijk artikel" @default.
- Q50442905 description "wissenschaftlicher Artikel" @default.
- Q50442905 description "επιστημονικό άρθρο" @default.
- Q50442905 description "мақолаи илмӣ" @default.
- Q50442905 description "наукова стаття, опублікована в червні 2015" @default.
- Q50442905 description "научна статия" @default.
- Q50442905 description "научная статья" @default.
- Q50442905 description "научни чланак" @default.
- Q50442905 description "научни чланак" @default.
- Q50442905 description "מאמר מדעי" @default.
- Q50442905 description "مقالة علمية نشرت في 10 يونيو 2015" @default.
- Q50442905 description "১০ জুন ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q50442905 description "บทความทางวิทยาศาสตร์" @default.
- Q50442905 description "სამეცნიერო სტატია" @default.
- Q50442905 name "Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study." @default.
- Q50442905 name "Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study." @default.
- Q50442905 type Item @default.
- Q50442905 label "Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study." @default.
- Q50442905 label "Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study." @default.
- Q50442905 prefLabel "Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study." @default.
- Q50442905 prefLabel "Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study." @default.
- Q50442905 P1433 Q50442905-818F6793-DC06-44FD-A044-AA2C7DF56A36 @default.
- Q50442905 P1476 Q50442905-A8C0C061-B1BF-4123-99F0-EB6F6FC4F7DA @default.
- Q50442905 P2093 Q50442905-0B02E5A9-A529-47F0-860D-59522276997A @default.
- Q50442905 P2093 Q50442905-43832A43-2A37-4929-9511-B7B3BAEA938F @default.
- Q50442905 P2093 Q50442905-4C997689-5C36-4D1C-A1DE-0339F956ED43 @default.
- Q50442905 P2093 Q50442905-63A26048-B960-4C60-BA96-61EA46618EB9 @default.
- Q50442905 P2093 Q50442905-994F2131-1C6E-4793-942E-7DFDFE27774B @default.
- Q50442905 P2093 Q50442905-9F7A2BB6-7115-443B-A4EE-AABC1F80FD45 @default.
- Q50442905 P2093 Q50442905-A1B0099B-0973-4A59-AC46-BB031A80B7BF @default.
- Q50442905 P2093 Q50442905-B87B2361-9E3F-437B-B27E-F8F44097CB6C @default.
- Q50442905 P2093 Q50442905-BAE4BFEC-08EB-4E35-8D56-DEA8B395F657 @default.
- Q50442905 P2093 Q50442905-C348C6B9-81F0-4119-9056-F36B91E54478 @default.
- Q50442905 P2093 Q50442905-F01DE846-F1ED-4752-A1BF-5A1437F3D938 @default.
- Q50442905 P2093 Q50442905-F6463385-B544-439D-A398-789E23ACD7E5 @default.
- Q50442905 P304 Q50442905-783A016E-A797-4E60-9271-CE30A6415406 @default.
- Q50442905 P31 Q50442905-A77E22FF-59DF-4D8D-89F0-6196D5B05B49 @default.
- Q50442905 P356 Q50442905-38CDADAF-EDFD-4886-BADE-061C0FD22E1A @default.
- Q50442905 P433 Q50442905-D61E4B37-60E9-4EE2-A21F-AD8955F79B70 @default.
- Q50442905 P478 Q50442905-FBCB47F2-14FF-4DBD-AAFE-C360A96FE16B @default.
- Q50442905 P50 Q50442905-809A1CA9-7542-4900-95D9-F1A9626C858B @default.
- Q50442905 P50 Q50442905-86AF5C7C-FA0A-4642-AEC4-6153CAC48A53 @default.
- Q50442905 P50 Q50442905-B71D6F4A-BBD6-463D-9962-A863C38249C7 @default.
- Q50442905 P577 Q50442905-2C9AE9DB-59AE-4C8D-810F-3FF81597C408 @default.
- Q50442905 P698 Q50442905-B827BACD-FE00-4934-8351-9D1B9B7D98E9 @default.
- Q50442905 P356 J.JHEP.2015.06.001 @default.
- Q50442905 P698 26071796 @default.
- Q50442905 P1433 Q15724402 @default.
- Q50442905 P1476 "Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study." @default.
- Q50442905 P2093 "Aiwu Ruth He" @default.
- Q50442905 P2093 "Baek-Yeol Ryoo" @default.
- Q50442905 P2093 "Chao-Hung Hung" @default.
- Q50442905 P2093 "Ho Yeong Lim" @default.
- Q50442905 P2093 "I-Shyan Sheen" @default.
- Q50442905 P2093 "Investigators’ Study Group" @default.